Stronger Statins Don't Up Kidney Injury Risk, Study Finds Title: Stronger Statins Don't Up Kidney Injury Risk, Study Finds Category: Health News Created: 6/19/2013 2:35:00 PM Last Editorial Review: 6/20/2013 12:00:00 AM
June 21, 2013 - MedicineNet.com
Amarin: FDA Panel Date, Misplaced Hype For Fixed-Dose Combo BEDMINSTER, NJ (TheStreet) -- Two items on Amarin up for discussion: First, we now have a confirmed date for the Vascepa "ANCHOR" FDA advisory panel. Second, the misguided reasons Amarin bulls are so excited about a fixed-dose combination of Vascepa and a cholesterol-lowering statin. Mark your calendars for Oct. 16. The FDA has scheduled an advisory panel to review Amarin's request to expand ...
June 19, 2013 - TheStreet.com
Kelly Brownell in AlterNet The fact that young kids may need statin drugs now is a sign of how bad we've made it,Brownell says. "If anything, this study should have sounded the loudest possible alarm bell that something needs to be done to provide better conditions...
Zhang Jun in International Herald Tribune This drug represents a new class of medications that might offer hope to those at risk for future cardiovascular disease whose lipid profiles are not effectively altered with statin therapy, and perhaps for about a quarter of those who have tried... Johns Hopkins http://www.google.com/url?q=http://en.wikipedia.org/wiki/Johns_Hopkins&source=dictionary&usg=AFQjCNEtzeyLNMG2VLwfufxA-75Bc89SZA Endocrine Today http://www.google.com/url?q=http://www.endocrinetoday.com/view.aspx%3Frid%3D61779&source=dictionary&usg=AFQjCNEL492ZEV4488Gz9OIPGBUpgrizYg Mar 10, 2010
94291 125327 station Most passengers were still asleep, but some were standing in the aisle waiting to get off at the Zibo railway station," one passenger surnamed Zhang told Xinhua.